VIDEO: SOD1 gene shows ‘great promise’ in ALS treatment

In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about treating patients with ALS with a mutation in the superoxide dismutase 1, or SOD1 gene.

Jha noted that tofersen, an FDA-approved treatment, shows "great promise" in the research of ALS and its genetic causes.